Metrics to compare | 6934 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6934PeersSector | |
|---|---|---|---|---|
P/E Ratio | −19.6x | −28.4x | −0.4x | |
PEG Ratio | 0.55 | 0.05 | 0.00 | |
Price/Book | 4.5x | 7.9x | 2.6x | |
Price / LTM Sales | 27.1x | 13.4x | 3.1x | |
Upside (Analyst Target) | 59.7% | 0.0% | 48.2% | |
Fair Value Upside | Unlock | −25.1% | 5.8% | Unlock |
HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells respiratory drug delivery systems in the United States, Europe, Africa, and Asia. The company’s products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides intellectual property, advanced technology, customization platforms, manufacturing and commercialization, and APSD analytical services. The company was founded in 2014 and is headquartered in Taipei, Taiwan.